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Summary
The sugar nucleotide UDP-N-acetylglucosamine
(UDP-GlcNAc) is an essential metabolite in both
prokaryotes and eukaryotes. In fungi, it is the precur-
sor for the synthesis of chitin, an essential component
of the fungal cell wall. UDP-N-acetylglucosamine
pyrophosphorylase (UAP) is the final enzyme in
eukaryotic UDP-GlcNAc biosynthesis, converting UTP
and N-acetylglucosamine-1-phosphate (GlcNAc-1P) to
UDP-GlcNAc. As such, this enzyme may provide an
attractive target against pathogenic fungi. Here, we
demonstrate that the fungal pathogen Aspergillus
fumigatus possesses an active UAP (AfUAP1) that
shows selectivity for GlcNAc-1P as the phosphosugar
substrate. A conditional mutant, constructed by
replacing the native promoter of the A. fumigatus uap1
gene with the Aspergillus nidulans alcA promoter,
revealed that uap1 is essential for cell survival and
important for cell wall synthesis and morphogenesis.
The crystal structure of AfUAP1 was determined and
revealed exploitable differences in the active site com-
pared with the human enzyme. Thus AfUAP1 could
represent a novel antifungal target and this work will
assist the future discovery of small molecule inhibi-
tors against this enzyme.
Introduction
Aspergillus fumigatus is one of the most important human
opportunistic fungal pathogens that is largely responsible
for the increased incidence of invasive aspergillosis (IA) in
immunocompromised patients (Latgé, 2001, Latgé, 1999,
Krappmann, 2006). Although three classes of antifungal
drugs have been licensed for the treatment of IA (Walsh
et al., 2008), its mortality rate remains extremely high
(50%; Brown et al., 2012) partly due to limited antifungal
treatment options, low efficiency and rising resistance
against current antifungal drugs. Therefore, a next gen-
eration of antifungal drugs is urgently needed. Like in
other pathogenic fungi, the cell wall of A. fumigatus is
essential for fungal growth and as a barrier against chemi-
cal and environmental challenges. It is composed mainly
of chitin, glucans and mannoproteins (Bernard and Latgé,
2001). Enzymes involved in cell wall biosynthetic path-
ways represent ideal drug targets as the fungal cell wall is
a unique structure not found in mammalian cells. The
newest echinocandin-class drugs (Douglas, 2001) are the
first and only antifungal compounds that target the fungal
cell wall by blocking β-1,3-D-glucan synthase (Douglas,
2001).
Chitin, accounting for 7–15% of the cell wall dry
weight (Gastebois et al., 2009), is a β(1,4)-linked
homopolymer of N-acetylglucosamine (GlcNAc) residues
and is synthesized from UDP-GlcNAc. In eukaryotes,
UDP-GlcNAc biosynthesis starts from the metabolite
fructose-6-phosphate (Fru-6P) followed by amination
to glucosamine 6-phosphate (GlcN-6P), acetylation to
N-acetylglucosamine-6-phosphate (GlcNAc-6P), isomeri-
zation to GlcNAc-1P and uridylation to the sugar nucleo-
tide UDP-GlcNAc (Milewski et al., 2006). The last step is
catalysed by UDP-GlcNAc pyrophosphorylase (UAP) uti-
lizing the high-energy pyrophosphate bonds from the
substrate UTP to yield UDP-GlcNAc. UAP also exists in
prokaryotes, usually referred to as GlmU, an enzyme
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with both acetylation and uridylation activity (Mengin-
Lecreulx and van Heijenoort, 1993; 1994). In contrast to
prokaryotes, the eukaryotic UAP enzymes are not
capable of catalysing the acetylation reaction and are
usually divided into mammalian and non-mammalian
UAPs. The crystal structures of Homo sapiens UAPs
(AGX1 and AGX2) have been determined (Peneff et al.,
2001) and consist of a pyrophosphorylation domain and
two further domains of unknown function. UAP from
Candia albicans (CaUAP1) (Maruyama et al., 2007) is
the only non-mammalian UAP for which a crystal struc-
ture has been reported and is structurally similar to
AGX1.
UAPs have been reported to be essential in many
species (Araujo et al., 2005; Schimmelpfeng et al., 2006;
Tonning et al., 2006; Zhang et al., 2008; Arakane et al.,
2011). For example, a null mutation of the Saccharomy-
ces cerevisiae uap1 gene resulted in aberrant morphol-
ogy and lethality (Mio et al., 1998). UAP is also essential
for the bloodstream forms of Trypanosoma brucei (Stokes
et al., 2008). No drug-like inhibitors have been described
for this class of enzyme in eukaryotes. Only recently, a
small-molecular compound from high-throughput screen-
ing exhibited inhibition of the uridyltransferase activity
of GlmU in Haemophilus influenzae (Mochalkin et al.,
2008).
Here we genetically and structurally validate UAP in
A. fumigatus (AfUAP1) as a potential antifungal target
using a conditional inactivation mutant of uap1 and by
determining the crystal structure of AfUAP1. Comparison
with the human enzyme revealed exploitable differences
in the active site providing a basis for the future design of
small molecule inhibitors for this enzyme class.
Results and discussion
A. fumigatus possesses an active UAP1 enzyme
selective for GlcNAc-1P and inhibited by UTP
A BLASTp search with the H. sapiens and S. cere-
visiae uap1 sequences (GenBank: BAA31202.1 and
BAA31203.1) revealed a putative uap1 gene in the
A. fumigatus genome. This gene, including two introns,
was amplified from genomic DNA and the introns were
subsequently removed by site-directed mutagenesis. The
ORF of the uap1 gene was cloned into pGEX-6P-1 and
overexpressed as a GST fusion protein in Escherichia coli.
Purification using glutathione sepharose beads followed
by GST cleavage and size exclusion chromatography
yielded 5 mg of pure AfUAP1 protein per litre of bacterial
culture.
The activity and substrate specificity of the AfUAP1
forward reaction were assessed by incubating the
enzyme with UTP and various phosphosugars followed
by analysing the products in a colorimetric assay coupled
with pyrophosphatase. AfUAP1 has a preference for
GlcNAc-1P as the phosphosugar substrate (Fig. 1A) as
does T. brucei UAP1 (Stokes et al., 2008). In contrast,
HsUAPs (AGX1 and AGX2) recognize either GalNAc-1P
or GlcNAc-1P to synthesize UDP-GalNAc or UDP-
GlcNAc respectively (Wang-Gillam et al., 1998; Peneff
et al., 2001).
AfUAP1 is also capable of catalysing the reverse reac-
tion, conversion of UDP-GlcNAc and pyrophosphate (PPi)
to UTP and GlcNAc-1P, as shown by the depletion of
UDP-GlcNAc and the direct formation of UTP using
HPAEC (Fig. 1B). Catalysis of this reaction has previously
only been reported for HsUAPs (Peneff et al., 2001).
The coupled colorimetric assay was used to measure
the Km values for GlcNAc-1P and UTP. AfUAP1 has a Km
of 34 ± 3 μM and 21 ± 2 μM for GlcNAc-1P and UTP,
respectively (Fig. 1C, Table 1), comparable to HsUAPs
[AGX1, 5.3 and 53 μM and AGX2, 6.0 and 49 μM respec-
tively (Peneff et al., 2001)]. However, the catalytic effi-
ciency of AfUAP1 is much lower than HsUAPs (Table 1).
Interestingly, AfUAP1 activity is inhibited by UTP at a
concentration above 1 mM (Fig. 1D) with a calculated Ki
of 1.9 ± 0.2 mM. The concentration of Mg2+ did not affect
this substrate inhibition (Supplementary Fig. S1). Sub-
strate inhibition could represent a biologically relevant
regulatory mechanism (Reed et al., 2010), indicating that
AfUAP1 may be involved in the regulation of UDP-GlcNAc
biosynthesis, similar to UAP from Giardia lamblia (Bulik
et al., 2000).
uap1 is an essential gene for A. fumigatus growth
Initial attempts to construct a deletion mutant by replacing
the uap1 gene with the pyrG resistance cassette failed
(86 transformants screened). Subsequently, a conditional
inactivation mutant was constructed by replacing the
native promoter of the uap1 gene with the Aspergillus
nidulans alcA promoter (PalcA), a tightly regulated promoter
induced by ethanol, glycerol or threonine, repressed by
glucose and completely repressed on YEPD medium
(Waring et al., 1989; Romero et al., 2003). The plasmid
pALuap1N that contains the Neurospora crassa pyr-4 gene
and PalcA fused to a 3′ truncated version of the uap1 gene,
was used to transform A. fumigatus CEA17 to generate
a conditional mutant by homologous recombination
(Fig. 2A). Two transformants, confirmed as the correct
mutants, were named as UAP1. PCR analysis revealed a
1217 bp fragment of the N. crassa pyr-4 gene and a
2548 bp fragment of PalcA–uap1 fusion was amplified from
the UAP1 strain but not from the wild type (WT, Fig. 2B). In
Southern blot confirmation when an 880 bp fragment of the
uap1 gene was used as a probe, the expected 2.7 kb
fragment was found in the WT, while the expected 1.2 kb
480 W. Fang et al. ■
© 2013 The Authors. Molecular Microbiology published by John Wiley & Sons Ltd., Molecular Microbiology, 89, 479–493
and 7.4 kb fragments were detected in the UAP1 strain
(Fig. 2C). When a 1.2 kb fragment of the N. crassa pyr-4
gene was used as probe, an expected 7.4 kb fragment was
detected in the UAP1 strain only (Fig. 2D). These results
confirmed that the promoter of the uap1 gene was replaced
by the PalcA promoter in the UAP1 strain.
Growth of the UAP1 strain was induced on solid
minimal medium (MM) containing 0.1 M glycerol, 0.1 M
ethanol or 0.1 M threonine (MMT) after 36 h at 37°C,
and completely inhibited on YEPD, CM or MM contain-
ing 1–3% glucose (Fig. 2E). Thus, expression of uap1 is
required for A. fumigatus viability.
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Fig. 1. AfUAP1 enzyme activity assay.
A. Substrate specificity against a range of phosphosugars. 100 nM of AfUAP1 was incubated with 2 mM UTP and 1.6 mM, 2.5 mM and 5 mM
phosphosugars for 10 min and the products were analysed in a colorimetric Biomol green assay coupled with pyrophosphatase.
B. HPAEC chromatogram for the AfUAP1 reverse reaction: 1, UTP standard; 2, UDP-GlcNAc standard; 3, 20 nM AfUAP1 in reaction; 4, no
AfUAP1 in reaction.
C. Representative determination of Km for GlcNAc-1-P and UTP. The results are the mean ± SD for three determinations.
D. Analysis of UTP substrate inhibition (Ki of 1.9 ± 0.2 mM) at concentrations >> Km. The results are the mean ± SD for three determinations.
Table 1. Kinetic parameters for AfUAP1 compared with HsUAPs (AGX1 and AGX2).
GlcNAc-1P UTP
Km (μM) Km (μM) Vmax (μM s−1) kcat (s−1) kcat/Km (μM−1 s−1)
AfUAP1 34 ± 3 21 ± 2 0.044 ± 0.001 2.2 ± 0.3 0.1048
AGX1 (Peneff et al., 2001) 5.3 53 NR 63.6 1.2
AGX2 (Peneff et al., 2001) 6 49 NR 68.6 1.4
The results are the mean ± SD for three determinations. NR, not reported.
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Fig. 2. Generation of a conditional inactivation uap1 mutant.
A. Schematic diagram of the strategy towards the conditional mutant.
B. PCR confirmation of the uap1 mutant using primer pairs of P7 & P8, P11 & P12, P9 & P10 to amplify the uap1 gene, the N. crassa pyr-4
gene and the fragment of PalcA- downstream of uap1 respectively.
C. Southern blot using an 880 bp fragment of the uap1 gene as a probe (marked as probe 1 in Fig. 2A).
D. Southern blot using a 1.2 kb HindIII internal fragment of the N. crassa pyr-4 gene as a probe (marked as probe 2 in Fig. 2A).
E. Growth of A. fumigatus strains on solid MM supplemented with 0.1 M glycerol, 0.1 M ethanol, 0.1 M threonine or 1%, 2%, 3% glucose,
YEPD or CM, using serial dilutions of 105–102 conidia.
482 W. Fang et al. ■
© 2013 The Authors. Molecular Microbiology published by John Wiley & Sons Ltd., Molecular Microbiology, 89, 479–493
uap1 is important for cell wall ultrastructure, integrity
and synthesis
When the UAP1 strain was inoculated on MM supple-
mented with varying concentrations of threonine and
glucose, growth was affected by the ratio of the latter
two components. On MM containing 0.1 M threonine and
0.01–0.1% glucose, growth of the UAP1 strain was par-
tially inhibited (Fig. 3A). To investigate the function of
AfUAP1, MM with 0.1 M threonine and 0.06% glucose
Fig. 3. The UAP1 strain under repressive growth conditions.
A. Growth on solid MM supplemented with 0.1 M threonine and 0.01%, 0.03%, 0.06% or 0.1% glucose, using serial dilutions of 105–102
conidia.
B. Semi-quantitative RT-PCR to amplify the tbp and uap1 gene. The RT-PCR products were separated on agarose gel (inset) and the relative
transcription level was calculated based on the band intensity.
C. Enzyme activity of the UAP1 strain grown under suppression condition. Intracellular proteins were extracted from mycelium and the enzyme
activity was detected by Biomol green assay coupled with pyrophosphatase.
D. TEM spore and mycelia morphology of strains grown in solid and liquid MMTG medium at 37°C for 36 h. Conidia (upper panel) and
mycelia (lower panel) were fixed and examined with an H-600 electron microscope (Hitachi). Bar = 0.5 μm.
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(MMTG) was selected for subsequent analysis. Under this
condition, total RNAs were prepared from mycelia and the
transcription levels of uap1 in the UAP1 strain and the WT
were examined by semi-quantitative RT-PCR. The tran-
scription of the uap1 gene was reduced to 64% of the WT
(Fig. 3B). Intracellular proteins were extracted from the
mycelium and investigated for AfUAP1 activity, revealing
a 39% reduction in activity of the UAP1 strain compared
with the WT strain (Fig. 3C).
Examination of the ultrastructure of the conidia and
hyphal cell wall showed that although the conidia in the
UAP1 strain have a thicker cell wall, it does not retain
melanin on its surface (Fig. 3D, upper panel), suggesting
differences in cell wall architecture. In contrast, the hyphae
of strain UAP1 had a thinner cell wall (Fig. 3D, lower panel).
We also tested the sensitivity of the UAP1 strain to
various chemical reagents. Using growth conditions (MMT
media) that induced expression of uap1, the UAP1 strain
showed no sensitivity to these reagents, similar to the WT
(Fig. 4A). However, in media (MMTG) that suppressed
induction of uap1 expression, the UAP1 strain showed an
increased sensitivity to Congo red, Calcofluor white, SDS
and hygromycin B as compared with the UAP1 strain
grown on MMTG plates alone (Fig. 4B), suggesting that
reduced expression of the uap1 led to a defect in cell wall
integrity.
To investigate these findings, cell wall contents were
analysed (Table 2). Compared with the WT strain, the
content of α-glucan and chitin in the mycelial cell wall in the
UAP1 strain decreased by 36% and 11% respectively.
Although the glycoprotein and β-glucan content in the
UAP1 strain were similar to the WT strain, GlcNAc released
from these proteins was reduced by 23% while mannose
increased by 59%. These results suggest that reduced
expression of the uap1 gene in A. fumigatus induced
decreased content of α-glucan, chitin and GlcNAc in the
cell wall.As Man and GlcNAc are both derived from Fru-6P,
the increase of GDP-Man could be the result of diversion of
Fru-6P away from UDP-GlcNAc biosynthesis in the UAP1
strain. Furthermore, the increased mannose content in cell
wall may represent part of a compensatory mechanism to
the weakened cell wall.
A potential response to a defective cell wall is activation
of the cell wall integrity (CWI) pathway via activation of the
MAP kinase MpkA (Jain et al., 2011). We studied the mpkA
transcription level and MpkA phosphorylation in the UAP1
strain under conditions of uap1 suppression. Real-time
PCR analysis revealed that mpkA was induced 1.8-fold
(P < 0.05 (Fig. 4C). A Western blot with a phospho-specific
antibody showed that MpkA was phosphorylated at a
higher level in the UAP1 strain than in the WT strain
(Fig. 4D), indicating that cell wall defects in the UAP1 strain
induced the activation of the MpkA-dependent CWI
pathway.
AfUAP1 is required for morphogenesis
The conidia of filamentous fungi undergo a series of
ordered morphological events including the switch from
isotropic to polar growth, the emergence of a second germ
tube and septation (Momany and Taylor, 2000). To study
the effect of AfUAP1 activity on hyphal development,
conidia from the UAP1 strain were allowed to adhere to
glass coverslips during incubation under conditions of
uap1 induction or suppression. Coverslips with adhering
germlings were fixed, stained with 4′,6-diamidino-2-
phenylindole (DAPI) and Calcofluor white and examined
under a fluorescence microscope. With uap1 induction
(MMT), 95% of the UAP1 strain displayed germination after
10 h incubation (Fig. 5A), while only 89% of the WT strain
showed germination after 12 h incubation, demonstrating
that the UAP1 strain displayed rapid conidial germination,
approximately 2 h earlier in initiation. No abnormal polarity
was observed for the UAP1 strain under this condition.
With uap1 suppression (MMTG), the WT had 89% germi-
nation at 9 h and 100% germination after 10 h, whereas the
UAP1 strain had only 65% germination at 14 h, and still had
11% ungerminated cells even after 16 h incubation. Apart
from 5 h delayed germination, the UAP1 strain germ tubes
formed anomalous bubbles from 14 h, displayed multiple
germ tubes on each basal cell and ballooned or highly
branched hyphal tips (Fig. 5B, white arrow). These results
suggest that UAP1 is involved in morphogenesis of
A. fumigatus.
The AGX1 and AfUAP1 active sites possess
exploitable differences
AGX1 and AfUAP1 share 59% identical at the amino acid
sequence level. To explore potential exploitable differ-
ences in the active site, the crystal structure of AfUAP1 was
determined to 2.1 Å resolution (Table 3, Fig. 6A). Similar to
the structures of other eukaryotic UAPs reported to date
(Peneff et al., 2001; Maruyama et al., 2007), the overall
structure of AfUAP1 reveals a three-domain fold with
the central catalytic domain flanked by two domains of
unknown function (Fig. 6A). The N-terminal domain of
AfUAP1 consists of four α-helices and six β-strands. The
central domain consists of 11 β-strands and 12 helices
adopting the Rossmann fold (Rao and Rossmann, 1973).
The C-terminal domain consists of four short β-strands and
a long helix that connects to the central domain (Fig. 6A).
AfUAP1 has a large active-site cleft, with its wall being
formed by the N- and C-terminal domains. Several of the
amino acids (e.g. equivalents of Thr140, Arg141 and
Lys148 in AfUAP1) shown to co-ordinate the phosphates
of nucleotides/phospho-sugars in complexes with other
UAP1 enzymes have been probed by mutagenesis and
shown to be essential for substrate binding/catalysis (Mio
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Fig. 4. Sensitivity of the UAP1 strain to chemical reagents and phosphorylation of MpkA.
A and B. Serial dilutions of conidia from 107 to 104 were spotted on solid (A) MMT, (B) MMTG containing 50 μg ml−1 Calcofluor white, 50 μg
ml−1 Congo red, 50 μg ml−1 SDS or 10 μg ml−1 hygromycin B. After incubation at 37°C for 48 h, the plates were taken out and photographed.
C. Real-time PCRs using primers P17 & P18, P19 & P20 were performed to analyse the transcription levels of MpkA in strains after 36 h
cultivation in MMTG. The experiment was repeated three times and the transcription level of WT was set as onefold.
D. Phosphorylated MpkA was detected using anti-phospho p44/42 MAPK antibodies. A Coomassie-stained gel is shown as loading control.
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et al., 1998; Peneff et al., 2001; Maruyama et al., 2007).
There are two homologous forms of UAP in Arabidopsis,
GlcNAc1pUT-1 and GlcNAc1pUT-2, showing different
substrate specificities. Both enzymes convert GlcNAc-1P
and GalNAc-1P to UDP-GlcNAc and UDP-GalNAc,
whereas only GlcNAc1pUT-2 converts Glc-1P to UDP-Glc
(Yang et al., 2010). Homology modelling using AGX1 as a
template revealed that the residues Glu335, Asn360,
Gly320 and Asn253 of GlcNAc1pUT-1 were involved in
recognition of the hexosamine moiety (Yang et al., 2010).
However, because all these residues are identical in
GlcNAc1pUT-2, AGX1 and AfUAP1, they are unlikely con-
tribute to UAP substrate specificity. The models also sug-
gested that the loop region between residues Pro312 and
Gly317 in GlcNAc1pUT-2 might account for its broader
substrate specificity (Yang et al., 2010). However, in the
AfUAP1 structure this region is positioned far from the
sugar moiety.
Apart from UAP, there are other pyrophosphorylases,
such as UDP-glucose pyrophosphorylase (UGPase,
A- and B-type) and UDP-sugar pyrophosphorylase
(USPase), that have relatively high structural homology to
UAP and carry out similar reactions with sugar-1P and
UTP (Kleczkowski et al., 2011). Compared with the struc-
tures of UGPase [PDB ID: 2ICY (McCoy et al., 2007);
3JUK (Kim et al., 2010)] and USPase [PDB ID: 3OH2
(Dickmanns et al., 2011)] AfUAP1 has a larger sugar
binding pocket that can accommodate the bulky N-acetyl
moiety of GlcNAc-1P whereas the sugar binding pockets
of the other pyrophosphorylases are too small to accom-
modate this substrate.
Compared with the human enzyme (Peneff et al.,
2001), the AfUAP1 active site possesses three substitu-
tions: Met134, Ser314 and Val357 (Fig. 6B), correspond-
ing to Leu108, Pro288 and Ala329 in AGX1 respectively.
These differences might account for the differences in
sugar phosphate specificity, with AfUAP1 being more
selective for GlcNAc-1P while AGX1 can utilize both
GlcNAc-1P and GalNAc-1P as substrates. Furthermore,
these differences in the active site between the fungal
enzyme and its human orthologue suggest that it may be
possible to identify selective inhibitors of AfUAP1.
Conclusion
Due to the increasing number of immunocompromised
patients, the morbidity and mortality of invasive fungal
infections (IFIs) are continuously high (Kousha et al.,
2011). However, current antifungal drugs have not kept
pace with this escalating medical demand. The numbers
of antifungal drug families for IFIs remain limited to poly-
enes, azoles and echinocandins (Denning and Hope,
2010). Both polyenes and azoles are effective in clinical
treatment but also have numerous adverse effects and
toxicity (Masia Canuto and Gutierrez Rodero, 2002;
Snelders et al., 2008; Kaji et al., 2009; Moen et al.,
2009) as they target the cell membrane that is also
present in mammalian cells. Only the echinocandin-
class drugs specifically target the fungal cell wall but
resistance has arisen recently (Perlin, 2007; Niimi and
Niimi, 2009). Therefore, new cell wall drug targets are
required.
UAP is the final enzyme involved in the biosynthesis of
UDP-GlcNAc, the direct precursor in the synthesis of cell
wall chitin. Here we have genetically validated UAP as an
attractive antifungal drug target in pathogenic fungi. The
essentiality of the uap1 gene in A. fumigatus was demon-
strated with a conditional inactivation mutant, which was
unable to grow under conditions of complete suppression
(Fig. 2D). This suggests that there is no alternative meta-
bolic route to synthesize UDP-GlcNAc in A. fumigatus.
Under conditions of partial gene suppression, to allow for
limited growth and phenotypic analysis, the mutant dis-
played a defective cell wall (Fig. 4B), decreased chitin and
GlcNAc content (Table 2), presumably as a direct conse-
quence of the decreased pools of the UDP-GlcNAc pre-
cursor. The MpkA-mediated cell wall integrity signalling
pathway plays an important role in maintaining cell wall
biogenesis under stress conditions. The increased level of
MpkA phosphorylation in the UAP1 strain is consistent
with activation of this pathway. AfUAP1 is also essential
for morphogenesis as shown by the mutant displaying
delayed germination and abnormal morphology under
conditions of uap1 suppression (Fig. 5B). This is in agree-
ment with reduced UDP-GlcNAc levels leading to reduced
Table 2. Chemical analysis of the cell wall in MMTG medium.
Strain







(μg)Protein (μg) GlcNAc (μg) Gal (μg) Man (μg)
WT 194 ± 4 0.22 ± 0.02 1.39 ± 0.13 2.23 ± 0.04 280 ± 29 322 ± 1 1282 ± 20
UAP1 188 ± 5 0.17 ± 0.01 1.25 ± 0.15 3.54 ± 0.39 178 ± 2 288 ± 13 1361 ± 59
Three aliquots of 10 mg lyophilized mycelia were used as independent samples for cell wall analysis, and the experiment was repeated twice. The
values shown are microgram of cell wall component per 10 mg dry mycelia (± SD).
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Fig. 5. Conidia germination of the UAP1 strain. A total of 107 freshly harvested conidia were inoculated into 10 ml of (A) MMT, (B) MMTG in
a Petri dish containing glass coverslips. After incubation at 37°C for specified time, the coverslips with adhering germlings were removed and
fixed. Coverslips were then washed with PBS, incubated for 20 min with 1 μg ml−1 DAPI, washed with PBS, and then incubated for 10 min with
a 10 μg ml−1 Calcofluor white, washed again. Germlings were photographed using a fluorescence microscope (Carl Zeiss). Typical
photographs are shown. Bar = 10 μm.
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levels of cell wall chitin synthesis, which is essential and
highly dynamic during morphogenesis.
To develop the next generation of non-toxic antifungals,
it is necessary to effectively target pathogen enzymes
rather than their human orthologues. Here, the crystal
structure of AfUAP1 revealed three non-conserved resi-
dues at the active site (Fig. 6B), which may account for
the stricter substrate specificity of AfUAP1 compared with
the human orthologues. These differences could be
exploitable for structure-guided design of fungal-specific
inhibitors. Interestingly, substrate inhibition of AfUAP1 by
UTP was also detected (Fig. 1D), which may represent a
possible mechanism for regulation of the UDP-GlcNAc
biosynthetic pathway in addition to the feedback inhibition
by UDP-GlcNAc reported for glucosamine-fructose-6-
phosphate aminotransferase (Kornfeld, 1967; Winterburn
and Phelps, 1971), the first enzyme in this pathway.
In conclusion, by combination of genetic and structural
approaches we have validated AfUAP1 as a potential
antifungal drug target. The structural insights reported
here will aid the future discovery and design of novel
antifungal compounds.
Experimental procedures
Reagents, strains and growth conditions
N-acetylglucosamine-1-phosphate (GlcNAc-1P), glucose-1-
phosphate (Glc-1P), galactose-1-phosphate (Gal-1P),
glucosamine-1-phosphate (GlcN-1P) and GlcNAc-6P were
purchased from Sigma-Aldrich, mannose-1-phosphate (Man-
1P) was purchased from Carbosynth, N-acetylgalactosamine-
1-phosphate (GalNAc-1P) was a kind gift from Prof. Peng
George Wang, Shandong University, China.
Aspergillus fumigatus strain YJ-407 (CGMCC0386) was
maintained on potato glucose (2%) agar slants (Xia et al.,
2001) and strain CEA17 (Weidner et al., 1998) was propa-
gated at 37°C on YGA (0.5% yeast extract, 2% glucose, 1.5%
Bacto-agar) with the addition of 5 mM uridine and uracil
(d’Enfert, 1996). The PalcA was induced by growth on MM
(Armitt et al., 1976) supplemented with 0.1 M glycerol, 0.1 M
threonine or 0.1 M ethanol as carbon sources. YEPD (2%
yeast extract, 2% glucose and 0.1% peptone) medium and
complete medium (CM; Cove, 1966) was utilized to repress
the PalcA. Strains were grown in liquid medium at 37°C, with
Table 3. Details of X-ray diffraction, data collection and structure
refinement.
AfUAP1






No. of reflections 246191
No. of unique reflections 64787
I/σ (I) 11.18 (2.06)
Completeness (%) 98.62 (99.7)
Redundancy 3.8 (3.8)
Rmerge (%) 11.3 (73.1)
RMSD from ideal geometry
Bond distances (Å) 0.018
Bond angle (°) 2.0
Rwork (%) 21.2
Rfree (%) 26.5
No. of residues 924
No. of water mol. 332
<B> protein(Å2) 20.6
Values in parenthesis are for the highest resolution shell. All
measured data were included in structure refinement.
Fig. 6. Crystal structure of AfUAP1.
A. A structural overview of AfUAP1. The N-terminal domain is
coloured in cyan, the central domain is coloured in yellow and the
C-terminal domains is coloured in salmon. Secondary structure
elements of each domain are coloured red (helices) and blue
(strands).
B. Close-up view of the AfUAP1 active site. A molecular surface of
AfUAP1 is shown, conserved residues with AGX1 are coloured in
grey, difference residues are coloured in violet, side-chains are
shown in cyan. A model of UDP-GlcNAc obtained by superposition
with the AGX1-UDP-GlcNAc complex (PDBID 1JV1; Peneff et al.,
2001) is shown as sticks with yellow carbon atoms. The predicted
position of Mg2+ was obtained by superposition with the UGPase
(PDBID 3JUK; Kim et al., 2010) and is shown as green sphere.
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shaking at 200 r.p.m. After approximately 3 days, mycelia
were harvested, washed with distilled water, frozen in liquid
nitrogen, and then ground using a mortar and pestle. The
powder was stored at −70°C for DNA, RNA and protein
extraction.
Conidia were prepared by propagating A. fumigatus strains
on solid medium for 48 h at 37°C. Spores were collected,
washed twice with PBS containing 0.1% Tween 20 and resus-
pended in distilled water. The concentration of spores was
verified by haemocytometer and viable counting.
Cloning of A. fumigatus uap1
The A. fumigatus uap1 gene contains three exons interrupted
by two introns at nucleotide positions 724–786 and 1522–
1595. Initially, the entire coding region of this gene was
obtained by PCR from A. fumigatus Af293 genomic DNA
(kindly provided by Jean-Paul Latgé, Institut Pasteur, France),
using the forward primer P1 (5′-CTCAATTGATGGCCGTA
GCTATCAAAGAGACAGTC-3′) and the reverse primer P2
(5′-CTGCGGCCGCTTATTCTTCTTTCTCAATGAAGGCTGG
TGCTTTG-3′), containing a recognition sequence (under-
lined) for MfeI (MunI) and NotI respectively. This was cloned
into the pSC-B vector (Stratagene) and the introns were
subsequently removed by PCR-based deletion mutagenesis
using the forward primer P3 (5′-GGCAAGATCTTGATGGA
GAGCAAGTTCAAGGTCGCTGTTGCTCCTGATGGAAACG
GTGG-3′), consisting exon I 3′ end (underlined) and exon II 5′
end (italic); and the reverse primer P4 (5′-GGCCTTTTAG
GAATTCAAGACCCTCTCCGCCATAGCTGATCAGTGGAGA
TACTTCAACAC-3′), consisting of exon III 5′ end (italic) and
exon II 3′ end (underlined). This mutagenesis regenerated the
uap1 open reading frame (Accession No. XM_741621, NCBI),
which was subsequently digested with MfeI and NotI and
subcloned into an EcoRI–NotI-digested pGEX-6P-1 vector
(GE Healthcare). This vector encodes a glutathione-S-
transferase (GST) tag followed by a PreScission protease
cleavage site. Finally, vector polylinker sequences and the
uap1 sequence encoding amino acid residues 1–27 were
removed by site-directed mutagenesis using the forward
and reverse mutagenesis primers P5 (5′-CTGGAAGTTC
TGTTCCAGGGGCCCTCTGCTGAAGAGTTCCAGCAGCTT
AG-3′) and P6 (5′-CTAAGCTGCTGGAACTCTTCAGCA
GAGGGCCCCTGGAACAGAACTTCCAG-3′), respectively,
resulting in the final expression plasmid pGEX-6P-1-AfUAP1
Δ1–27.
Construction of the uap1 conditional inactivation mutant
Plasmid pAL3 (Waring et al., 1989) containing the PalcA and
the N. crassa pyr-4 gene as a fungal selectable marker was
used to construct a suitable vector allowing the replacement
of the native promoter of the uap1 with the PalcA. An 880 bp
fragment from −40 to +840 of the uap1 genomic DNA
sequence was amplified with primers P7 (5′-GGGGTACCCC
CTCTTCGTCTGATACGCTC-3′), containing a KpnI site and
P8 (5′-GCTCTAGAGGATGTAAGAAGGGCCTGGTAG-3′),
containing an XbaI site. The PCR-amplified fragment was
cloned into the expression vector pAL3 to yield pALuap1N
and confirmed by sequencing. The pALuap1N was used to
transform A. fumigatus strain CEA17 by PEG-mediated
fusion of protoplasts (Langfelder et al., 2002) and positive
transformants were selected by uridine/uracil autotrophy. The
transformants were confirmed by PCR and Southern blot
analysis. For PCR analysis, three pairs of primers (P7 & P8,
P9 & P10 and P11 & P12) were utilized. Primers P7 and
P8 were used to amplify an 880 bp fragment of the uap1
gene. P9 (5′-TCGGGATAGTTCCGACCTAGGA-3′) and P10
(5′-TCCGCATTGCGTAAGGTTGC-3′) were used to amplify
a 2.54 kb fragment from the PalcA to a downstream flanking
region of the uap1 gene. Primers P11 (5′-AAACGCA
AATCACAACAGCCAAC-3′) and P12 (5′-CTATGCCAGAC
GCTCCCGG-3′) were used to amplify the N. crassa pyr-4
gene. For Southern blotting, genomic DNA was digested with
PstI, separated by electrophoresis, and transferred to a nylon
membrane (Zeta-probe+, Bio-Rad). The 880 bp fragment of
the uap1 gene and a 1.2 kb HindIII fragment of the N. crassa
pyr-4 gene from pAL3 were used as probes. Labelling and
visualization were performed using the DIG DNA labelling
and detection kit (Roche Applied Science) according to the
manufacturer’s instructions.
Semi-quantitative RT-PCR
Total RNAs from the spores cultured in liquid MM supple-
mented with 0.1 M threonine and 0.06% glucose (MMTG)
were extracted using Trizol reagent (Invitrogen). Comple-
mentary DNA synthesis was performed with 5 μg of RNA
using the SuperScript-First-Strand Synthesis System (Fer-
mentas). Primers P13 (5′-CCACCTTGCAAAACATTGTT-3′)
and P14 (5′-TACCAGAAAGCACAGGATAG-3′) were used to
amplify a 515 bp fragment containing the intron and exon of
the tbp gene (encoding TATA-binding protein). Primers
P15 (5′-AGTTCAAGGTCG CTGTTGCT-3′) and P16 (5′-
GGAGATACTTCAACACCAAC-3′) were used to amplify a
750 bp fragment containing the intron and exon of the uap1.
The tbp and uap1 fragments were amplified in one tube with
primer pairs (P13 & P14 and P15 & P16) in a 1:2 ratio.
Twenty-eight PCR cycles (94°C for 45 s, 58°C for 50 s and
72°C for 50 s) were performed. The products were loaded
onto an ethidium bromide-stained 1.2% agarose gel and
quantification of the bands was performed by Quantity One
(Bio-Rad). Band density ratios were calculated by dividing
normalized values of uap1 by tbp.
Analysis of the uap1 conditional mutant
To monitor the cell wall structures, the conidia and mycelia
grown in solid and liquid MMTG or MM containing 0.1 M
threonine (MMT) were fixed and examined with an H-600
electron microscope as described by Li et al. (2007).
To test the sensitivity to chemical reagents, serial dilutions
of conidia from 107 to 104 were spotted on MMT or MMTG
plates containing 50 μg ml−1 of Calcofluor white, 50 μg ml−1 of
Congo red, 50 μg ml−1 of SDS or 10 μg ml−1 of hygromycin B
respectively. After incubation at 37°C for 48 h, the plates were
taken out and photographed.
For the chemical analysis of the cell wall, conidia were
inoculated into 100 ml MMTG liquid medium at a concentra-
tion of 106 conidia ml−1 and incubated at 37°C with shaking at
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200 r.p.m. for 36 h. The mycelia were harvested, washed with
deionized water and stored at −80°C. The cell wall compo-
nents were isolated and assayed as described previously
(Fang et al., 2009). Three independent samples of lyophilized
mycelia pad were used for cell wall analysis, and the experi-
ment was repeated twice.
For examination of nuclei, septa and cell wall staining at
the germination stage, 10 ml of MMT or MMTG medium was
inoculated with 107 freshly harvested conidia in a Petri dish
containing glass coverslips. After incubation at 37°C for the
time indicated, the coverslips with adhering germlings were
removed and fixed in 4% formaldehyde in PBS which contain
0.2% Triton X-100 for 30 min. The coverslips were then
washed with PBS, incubated for 20 min with 1 μg ml−1 DAPI
(Sigma). After PBS wash the coverslips were then incubated
for 10 min with 10 μg ml−1 Calcofluor white (Sigma), washed
again, then the germlings were photographed using a fluo-
rescence microscope (Carl Zeiss).
Detection of MpkA
To detect the transcription level of MpkA, total RNAs and
cDNA were prepared as described above. Primers P17 (5′-
ACCAAAGCTATCGACGTGTG-3′) and P18 (5′-AGTCCCG
GCCTTTGAAGAAA-3′) were used to amplify a 78 bp frag-
ment of the mpkA (AFUA_4G13720), and primers P19
(5′-CCACCTTGCAAAACATTGTT-3′) and P20 (5′-TACTCT
GCATTTCGCGCATG-3′) were used for an 80 bp fragment of
tbp. To exclude contamination of cDNA preparations with
genomic DNA, primers were designed to amplify regions
containing one intron in the gene. PCR reactions were per-
formed with a LightCycler® (Roche) instrument loaded with
eight strip PCR tubes (Roche). Each PCR reaction mixture
(20 μl) contained 5 μl sample cDNA, 10 μl SYBR Premix Ex
Taq™ from SYBR Premix Ex Taq™ Kit (TAKARA), 4.2 μl
ddH2O and 0.2 μM of each pair of primers. Thermal cycling
conditions were 95°C for 50 s, followed by 40 cycles of 95°C
for 5 s, 60°C for 20 s. Real-time PCR data were acquired
using Sequence Detection software. Samples isolated from
different strains were tested in triplicate.
To detect the phosphorylation level of MpkA, the mycelia
were incubated, harvested and ground as previously
described. The powdered mycelia were suspended in lysis
buffer (200 mM Tris-HCl, pH 8.0, 20 mM EDTA, 1 mM phenyl-
methanesulphonyl fluoride) and incubated on ice for 20 min.
Proteins in the supernatant were collected by centrifugation
(16 000 g at 4°C for 10 min). Protein concentration was deter-
mined by the Lowry method (Bensadoun and Weinstein, 1976;
Peterson, 1977). Thirty micrograms of cellular proteins was
separated by 10% SDS-PAGE and transformed to PVDF
membrane (Millipore, USA). The phosphorylation of MpkAwas
examined using anti-phospho-p44/42 MAPK antibody (Cell
Signaling Technology, USA). The primary antibody was
detected usingAnti-Rabbit IgG Horseradish peroxidase (HRP)
Conjugate (Promega) and EnlightTM reagents (Engreen Bio-
system, China).
Expression and purification of AfUAP1
The N-terminally truncated pGEX-6P-1-AfUAP1 Δ1–27
plasmid was transformed into E. coli BL21 (DE3) pLysS and
a single colony inoculated into 100 ml of Luria–Bertani (LB)
medium containing 0.1 mg ml−1 ampicillin and incubated at
37°C overnight with shaking at 200 r.p.m. Ten millilitres of the
overnight culture was used to inoculate 1 l LB medium and
grown to an OD600 of 0.6. Expression of the GST fusion
protein was induced at room temperature with 250 μM of
IPTG (isopropyl-β-D-thiogalactopyranoside) and the cultures
incubated for a further 20 h. The cells were then harvested by
centrifugation at 3500 g for 30 min, resuspended in 25 ml of
lysis buffer (25 mM Tris-HCl, 150 mM NaCl, pH 7.5 contain-
ing 10 mg ml−1 DNase, 0.5 mg ml−1 lysozyme and a tablet of
protease inhibitor cocktail) (Bensadoun and Weinstein, 1976)
and lysed by sonication on ice. The cell lysate was centri-
fuged at 40 000 g for 30 min to remove cell debris and the
supernatant was incubated with pre-washed glutathione
sepharose beads (GE Healthcare) at 4°C on a rotating plat-
form for 2 h. The GST-AfUAP1 fusion protein was isolated
by centrifugation and washed with buffer (25 mM Tris-HCl,
150 mM NaCl, pH 7.5). The GST tag was cleaved overnight
with PreScission protease (50 μg protease per ml of beads).
The cleaved protein was filtered from the beads, concen-
trated to 5 ml and loaded onto a Superdex 200 column
(Amersham Bioscience) equilibrated with buffer and eluted at
a flow rate of 1 ml min−1 in the same buffer. The fractions were
verified by SDS-PAGE. Pure fractions were pooled and con-
centrated to 20 mg ml−1 using a 10 kDa cut-off Vivaspin con-
centrator (GE Healthcare).
Enzyme kinetics
AfUAP1 steady-state kinetics was studied under linear condi-
tions with no more than 10% of substrate conversion. The
activity of AfUAP1 for the forward reaction was determined as
described by Mok and Edwards (2005a). Briefly, the assay was
performed in triplicate in a 96-well plate at 37°C with each well
containing 50 mM Tris-HCl, pH 7.5, 10 mM MgCl2, 10% (v/v)
glycerol, 1 mM DTT, 0.4 units of pyrophosphatase, 20 nM of
AfUAP1 and varying concentrations of GlcNAc-1P and UTP in
a final volume of 100 μl. The reaction was incubated for 10 min
and terminated by the addition of 100 μl Biomol green [0.03%
w/v malachite green, 0.2% w/v ammonium molybdate and
0.5% (v/v) Triton X-100 in 0.7 N HCl] followed by 20 min
incubation at room temperature. The absorbance intensity
was measured at 620 nm using a Spectra max 340 PC
(Molecular Devices) and data were analysed with non-linear
regression analysis using GRAFIT 5 (Leatherbarrow, 2001)
with the default equations for first-order reaction rates and
Michaelis-Menten steady-state kinetics.
Catalysis of the reverse reaction was analysed by High
Performance Anion Exchange Chromatography (HPAEC,
Dionex) using conditions adapted from Tomiya et al. (2002).
The eluent was monitored at 260 nm for the presence of UTP
and UDP-GlcNAc, with peaks assigned by comparison to the
commercial standards. The 100 μl reaction contained 200 μM
UDP-GlcNAc, 100 μM pyrophosphate, 10 mM MgCl2, 1 mM
DTT, 2% glycerol and 20 nM AfUAP1 in 10 mM Tris-HCl
pH 7.5. This was incubated for 30 min, alongside a negative
control without the enzyme, and the reaction terminated by
the addition of 10 μl of 100 mM NaOH prior to analysis.
Different phosphosugars: Glc-1P, Gal-1P, GlcN-1P, Man-
1P, GalNAc-1P and GlcNAc-6P, were used to investigate
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substrate specificity using the Biomol green assay described
above with GlcNAc-1P as a positive control. 2 mM UTP and
1.6 mM, 2.5 mM, 5 mM phosphosugars were used with
100 nM of AfUAP1.
For the in vivo AfUAP1 activity assay, ground frozen
powder from different strains was dissolved in 50 mM Tris-
HCl pH 7.5 and placed on ice for 30 min. Intracellular proteins
were collected by centrifugation and protein concentration
was determined by Lowery method same as before. AfUAP1
activity was determined as described previously (Mok and
Edwards, 2005a,b).
Crystallization, data collection and
structure determination
AfUAP1 at a concentration of 20 mg ml−1 stock solution was
used for crystallization trials using the sitting drop method.
Each drop contained an equal volume of 0.6 μl of protein and
0.6 μl of reservoir solution (mother liquor). Crystals grew
after 3 days in a mother liquor of 0.2 M sodium acetate
trihydrate and 20% PEG3350 and were cryoprotected in
this solution supplemented with 10% glycerol. Data were
collected at the European Synchrotron Radiation Facility
(ESRF) (Grenoble, France) and processed with the HKL
suite (Otwinowski and Minor, 1997). The structure was
solved by molecular replacement using MOLREP (Vagin and
Teplyakov, 1997) with the CaUAP1 structure (PDB ID 2YQS;
Maruyama et al., 2007) as the search model. REFMAC
(Murshudov et al., 1997) was used for further refinement and
iterated with model building using COOT (Emsley and
Cowtan, 2004). Images were produced with PyMol (DeLano,
2004). The atomic co-ordinates and structure factors of
AfUAP1 have been deposited in the Protein Data Bank with
accession code 4BMA.
Acknowledgements
The authors would like to list the following author contribu-
tions: M.A.J.F., C.J. and D.M.F.v.A. conceived the study; W.F.,
O.G.R., R.H.-G., M.A.J.F., C.J. and D.M.F.v.A. designed the
experimental approach; W.F., T.D., O.G.R., R.H.-G., A.F.M.I.
and D.M.F.v.A. conducted the experiments; W.F., O.G.R.,
R.H.-G., M.A.J.F., C.J. and D.M.F.v.A. interpreted the data;
and W.F., O.G.R., R.H.-G., C.J. and D.M.F.v.A. wrote the
manuscript.
The authors would like to thank the European Synchrotron
Radiation facility (ESRF), Grenoble, for beamline time. We
wish to thank Prof. Jean-Paul Latgé for generously donating
the Aspergillus fumigatus cDNA and Prof. Peng George
Wang for providing GalNAc-1P. We also like to thank
Deborah Lockhart for critically reading the manuscript. This
work was funded by MRC Programme Grant G0900138 to
D.M.F.v.A. and the National Natural Science Foundation of
China (31030025) to C. Jin. D.M.F.v.A. is funded by a Well-
come Trust Senior Research Fellowship (WT087590MA).
References
Arakane, Y., Baguinon, M.C., Jasrapuria, S., Chaudhari, S.,
Doyungan, A., Kramer, K.J., et al. (2011) Both UDP
N-acetylglucosamine pyrophosphorylases of Tribolium
castaneum are critical for molting, survival and fecundity.
Insect Biochem Mol Biol 41: 42–50.
Araujo, S.J., Aslam, H., Tear, G., and Casanova, J. (2005)
Mummy/cystic encodes an enzyme required for chitin and
glycan synthesis, involved in trachea, embryonic cuticle
and CNS development – analysis of its role in Drosophila
tracheal morphogenesis. Dev Biol 288: 179–193.
Armitt, S., McCullough, W., and Roberts, C.F. (1976) Analysis
of acetate non-utilizing (acu) mutants in Aspergillus nidu-
lans. J Gen Microbiol 92: 263–282.
Bensadoun, A., and Weinstein, D. (1976) Assay of proteins in
the presence of interfering materials. Anal Biochem 70:
241–250.
Bernard, M., and Latgé, J. (2001) Aspergillus fumigatus cell
wall: composition and biosynthesis. Med Mycol 39 (Suppl.
1): 9–17.
Brown, G.D., Denning, D.W., Gow, N.A., Levitz, S.M., Netea,
M.G., and White, T.C. (2012) Hidden killers: human fungal
infections. Sci Transl Med 4: 165rv113.
Bulik, D.A., van Ophem, P., Manning, J.M., Shen, Z.,
Newburg, D.S., and Jarroll, E.L. (2000) UDP-N-
acetylglucosamine pyrophosphorylase, a key enzyme in
encysting Giardia, is allosterically regulated. J Biol Chem
275: 14722–14728.
Cove, D.J. (1966) The induction and repression of nitrate
reductase in the fungus Aspergillus nidulans. Biochim
Biophys Acta 113: 51–56.
DeLano, W.L. (2004) Use of PYMOL as a communication tool
for molecular science. Abstr Pap Am Chem Soc 228: 030-
CHED.
Denning, D.W., and Hope, W.W. (2010) Therapy for fungal
diseases: opportunities and priorities. Trends Microbiol 18:
195–204.
Dickmanns, A., Damerow, S., Neumann, P., Schulz, E.C.,
Lamerz, A.C., Routier, F.H., and Ficner, R. (2011) Struc-
tural basis for the broad substrate range of the UDP-sugar
pyrophosphorylase from Leishmania major. J Mol Biol 405:
461–478.
Douglas, C.M. (2001) Fungal beta(1,3)-D-glucan synthesis.
Med Mycol 39 (Suppl. 1): 55–66.
Emsley, P., and Cowtan, K. (2004) Coot: model-building tools
for molecular graphics. Acta Crystallogr D Biol Crystallogr
60: 2126–2132.
d’Enfert, C. (1996) Selection of multiple disruption events in
Aspergillus fumigatus using the orotidine-5′-decarboxylase
gene, pyrG, as a unique transformation marker. Curr Genet
30: 76–82.
Fang, W., Yu, X., Wang, B., Zhou, H., Ouyang, H., Ming, J.,
and Jin, C. (2009) Characterization of the Aspergillus
fumigatus phosphomannose isomerase Pmi1 and its
impact on cell wall synthesis and morphogenesis. Microbi-
ology 155: 3281–3293.
Gastebois, A., Clavaud, C., Aimanianda, V., and Latgé, J.
(2009) Aspergillus fumigatus: cell wall polysaccharides,
their biosynthesis and organization. Future Microbiol 4:
583–595.
Jain, R., Valiante, V., Remme, N., Docimo, T., Heinekamp, T.,
Hertweck, C., et al. (2011) The MAP kinase MpkA controls
cell wall integrity, oxidative stress response, gliotoxin pro-
duction and iron adaptation in Aspergillus fumigatus. Mol
Microbiol 82: 39–53.
Structural and genetic validation of AfUAP1 491
© 2013 The Authors. Molecular Microbiology published by John Wiley & Sons Ltd., Molecular Microbiology, 89, 479–493
Kaji, Y., Yamamoto, E., Hiraoka, T., and Oshika, T. (2009)
Toxicities and pharmacokinetics of subconjunctival injec-
tion of liposomal amphotericin B. Graefes Arch Clin Exp
Ophthalmol 247: 549–553.
Kim, H., Choi, J., Kim, T., Lokanath, N.K., Ha, S.C., Suh,
S.W., et al. (2010) Structural basis for the reaction mecha-
nism of UDP-glucose pyrophosphorylase. Mol Cells 29:
397–405.
Kleczkowski, L.A., Geisler, M., Fitzek, E., and Wilczynska, M.
(2011) A common structural blueprint for plant UDP-sugar-
producing pyrophosphorylases. Biochem J 439: 375–379.
Kornfeld, R. (1967) Studies on L-glutamine D-fructose
6-phosphate amidotransferase. I. Feedback inhibition by
uridine diphosphate-N-acetylglucosamine. J Biol Chem
242: 3135–3141.
Kousha, M., Tadi, R., and Soubani, A.O. (2011) Pulmonary
aspergillosis: a clinical review. Eur Respir Rev 20: 156–174.
Krappmann, S. (2006) Tools to study molecular mechanisms
of Aspergillus pathogenicity. Trends Microbiol 14: 356–
364.
Langfelder, K., Gattung, S., and Brakhage, A.A. (2002) A
novel method used to delete a new Aspergillus fumigatus
ABC transporter-encoding gene. Curr Genet 41: 268–274.
Latgé, J.P. (1999) Aspergillus fumigatus and aspergillosis.
Clin Microbiol Rev 12: 310–350.
Latgé, J.P. (2001) The pathobiology of Aspergillus fumigatus.
Trends Microbiol 9: 382–389.
Leatherbarrow, R.J. (2001) Grafit Version 5. Horley, UK:
Erithacus software Ltd.
Li, H., Zhou, H., Luo, Y., Ouyang, H., Hu, H., and Jin, C.
(2007) Glycosylphosphatidylinositol (GPI) anchor is
required in Aspergillus fumigatus for morphogenesis and
virulence. Mol Microbiol 64: 1014–1027.
McCoy, J.G., Bitto, E., Bingman, C.A., Wesenberg, G.E.,
Bannen, R.M., Kondrashov, D.A., and Phillips, G.N., Jr
(2007) Structure and dynamics of UDP-glucose pyrophos-
phorylase from Arabidopsis thaliana with bound UDP-
glucose and UTP. J Mol Biol 366: 830–841.
Maruyama, D., Nishitani, Y., Nonaka, T., Kita, A., Fukami,
T.A., Mio, T., et al. (2007) Crystal structure of uridine-
diphospho-N-acetylglucosamine pyrophosphorylase from
Candida albicans and catalytic reaction mechanism. J Biol
Chem 282: 17221–17230.
Masia Canuto, M., and Gutierrez Rodero, F. (2002) Antifungal
drug resistance to azoles and polyenes. Lancet Infect Dis
2: 550–563.
Mengin-Lecreulx, D., and van Heijenoort, J. (1993) Identifi-
cation of the glmU gene encoding N-acetylglucosamine-1-
phosphate uridyltransferase in Escherichia coli. J Bacteriol
175: 6150–6157.
Mengin-Lecreulx, D., and van Heijenoort, J. (1994) Copurifi-
cation of glucosamine-1-phosphate acetyltransferase and
N-acetylglucosamine-1-phosphate uridyltransferase activi-
ties of Escherichia coli: characterization of the glmU gene
product as a bifunctional enzyme catalyzing two subse-
quent steps in the pathway for UDP-N-acetylglucosamine
synthesis. J Bacteriol 176: 5788–5795.
Milewski, S., Gabriel, I., and Olchowy, J. (2006) Enzymes of
UDP-GlcNAc biosynthesis in yeast. Yeast 23: 1–14.
Mio, T., Yabe, T., Arisawa, M., and Yamada-Okabe, H. (1998)
The eukaryotic UDP-N-acetylglucosamine pyrophosphory-
lases. Gene cloning, protein expression, and catalytic
mechanism. J Biol Chem 273: 14392–14397.
Mochalkin, I., Lightle, S., Narasimhan, L., Bornemeier, D.,
Melnick, M., Vanderroest, S., and McDowell, L. (2008)
Structure of a small-molecule inhibitor complexed with
GlmU from Haemophilus influenzae reveals an allosteric
binding site. Protein Sci 17: 577–582.
Moen, M.D., Lyseng-Williamson, K.A., and Scott, L.J. (2009)
Liposomal amphotericin B: a review of its use as empirical
therapy in febrile neutropenia and in the treatment of inva-
sive fungal infections. Drugs 69: 361–392.
Mok, M.T., and Edwards, M.R. (2005a) Critical sources of
error in colorimetric assay for UDP-N-acetylglucosamine
pyrophosphorylase. Anal Biochem 343: 341–343.
Mok, M.T., and Edwards, M.R. (2005b) Kinetic and physical
characterization of the inducible UDP-N-acetylglucosamine
pyrophosphorylase from Giardia intestinalis. J Biol Chem
280: 39363–39372.
Momany, M., and Taylor, I. (2000) Landmarks in the early
duplication cycles of Aspergillus fumigatus and Aspergillus
nidulans: polarity, germ tube emergence and septation.
Microbiology 146 (Part 12): 3279–3284.
Murshudov, G.N., Vagin, A.A., and Dodson, E.J. (1997)
Refinement of macromolecular structures by the
maximum-likelihood method. Acta Crystallogr D Biol Crys-
tallogr 53: 240–255.
Niimi, K., and Niimi, M. (2009) The mechanisms of resistance
to echinocandin class of antifungal drugs. Nippon Ishinkin
Gakkai Zasshi 50: 57–66.
Otwinowski, Z., and Minor, A. (1997) Processing of X-ray
diffraction data collected in oscillation mode. Methods
Enzymol 276: 307–326.
Peneff, C., Ferrari, P., Charrier, V., Taburet, Y., Monnier, C.,
Zamboni, V., et al. (2001) Crystal structures of two human
pyrophosphorylase isoforms in complexes with UDPGl-
c(Gal)NAc: role of the alternatively spliced insert in the
enzyme oligomeric assembly and active site architecture.
EMBO J 20: 6191–6202.
Perlin, D.S. (2007) Resistance to echinocandin-class antifun-
gal drugs. Drug Resist Updat 10: 121–130.
Peterson, G.L. (1977) A simplification of the protein assay
method of Lowry et al. which is more generally applicable.
Anal Biochem 83: 346–356.
Reed, M.C., Lieb, A., and Nijhout, H.F. (2010) The biological
significance of substrate inhibition: a mechanism with
diverse functions. Bioessays 32: 422–429.
Romero, B., Turner, G., Olivas, I., Laborda, F., and De Lucas,
J.R. (2003) The Aspergillus nidulans alcA promoter drives
tightly regulated conditional gene expression in Aspergillus
fumigatus permitting validation of essential genes in this
human pathogen. Fungal Genet Biol 40: 103–114.
Rao, S.T., and Rossmann, M.G. (1973) Comparison of super-
secondary structures in proteins. Journal of Molecular
Biology 76: 241–256.
Schimmelpfeng, K., Strunk, M., Stork, T., and Klambt, C.
(2006) Mummy encodes an UDP-N-acetylglucosamine-
diphosphorylase and is required during Drosophila dorsal
closure and nervous system development. Mech Dev 123:
487–499.
Snelders, E., van der Lee, H.A., Kuijpers, J., Rijs, A.J., Varga,
J., Samson, R.A., et al. (2008) Emergence of azole resist-
492 W. Fang et al. ■
© 2013 The Authors. Molecular Microbiology published by John Wiley & Sons Ltd., Molecular Microbiology, 89, 479–493
ance in Aspergillus fumigatus and spread of a single resist-
ance mechanism. PLoS Med 5: e219.
Stokes, M.J., Guther, M.L., Turnock, D.C., Prescott, A.R.,
Martin, K.L., Alphey, M.S., and Ferguson, M.A. (2008) The
synthesis of UDP-N-acetylglucosamine is essential for
bloodstream form Trypanosoma brucei in vitro and in vivo
and UDP-N-acetylglucosamine starvation reveals a hierar-
chy in parasite protein glycosylation. J Biol Chem 283:
16147–16161.
Tomiya, N., Ailor, E., Lawerence, S.M., Bettenbaugh, M.J.,
and Lee, Y.C. (2002) Determination of nucleotides and
sugar nucleotides involved in protein glycosylation by High-
performance Anion-Exchange Chromatography: sugar
nucleotide contents in cultured insect cells and mammalian
cells. Anal Biochem 293: 129–137.
Tonning, A., Helms, S., Schwarz, H., Uv, A.E., and Moussian,
B. (2006) Hormonal regulation of mummy is needed for
apical extracellular matrix formation and epithelial morpho-
genesis in Drosophila. Development 133: 331–341.
Vagin, A., and Teplyakov, A. (1997) MOLREP: an automated
program for molecular replacement. J Appl Cryst 30: 1022–
1025.
Walsh, T.J., Anaissie, E.J., Denning, D.W., Herbrecht, R.,
Kontoyiannis, D., Marr, K.A., et al. (2008) Treatment of
aspergillosis: clinical practice guidelines of the Infectious
Diseases Society of America. Clin Infect Dis 46: 327–360.
Wang-Gillam, A., Pastuszak, I., and Elbein, A.D. (1998) A
17-amino acid insert changes UDP-N-acetylhexosamine
pyrophosphorylase specificity from UDP-GalNAc to UDP-
GlcNAc. J Biol Chem 273: 27055–27057.
Waring, R.B., May, G.S., and Morris, N.R. (1989) Characteri-
zation of an inducible expression system in Aspergillus
nidulans using alcA and tubulin-coding genes. Gene 79:
119–130.
Weidner, G., d’Enfert, C., Koch, A., Mol, P.C., and Brakhage,
A.A. (1998) Development of a homologous transformation
system for the human pathogenic fungus Aspergillus
fumigatus based on the pyrG gene encoding orotidine
5′-monophosphate decarboxylase. Curr Genet 33: 378–
385.
Winterburn, P.J., and Phelps, C.F. (1971) Studies on the
control of hexosamine biosynthesis by glucosamine syn-
thetase. Biochem J 121: 711–720.
Xia, G., Jin, C., Zhou, J., Yang, S., and Zhang, S. (2001) A
novel chitinase having a unique mode of action from Asper-
gillus fumigatus YJ-407. Eur J Biochem 268: 4079–4085.
Yang, T., Echols, M., Martin, A., and Bar-Peled, M. (2010)
Identification and characterization of a strict and a promis-
cuous N-acetylglucosamine-1-P uridylyltransferase in
Arabidopsis. Biochem J 430: 275–284.
Zhang, W., Jones, V.C., Scherman, M.S., Mahapatra, S.,
Crick, D., Bhamidi, S., et al. (2008) Expression, essential-
ity, and a microtiter plate assay for mycobacterial GlmU,
the bifunctional glucosamine-1-phosphate acetyltrans-
ferase and N-acetylglucosamine-1-phosphate uridyltrans-
ferase. Int J Biochem Cell Biol 40: 2560–2571.
Supporting information
Additional supporting information may be found in the online
version of this article at the publisher’s web-site.
Structural and genetic validation of AfUAP1 493
© 2013 The Authors. Molecular Microbiology published by John Wiley & Sons Ltd., Molecular Microbiology, 89, 479–493
